Cannabis Corner: These stocks all have bright futures

Article Excerpt

Canada legalized cannabis four years ago. While demand has been steady, stiff competition has cut selling prices significantly. Meanwhile, advertising restrictions and plain packaging rules make it hard to build brands that win customer loyalty. Still, we think some companies have a distinct edge—including their prospects for added sales in the U.S. as President Joe Biden stirs talk that the federal government could eventually decriminalize cannabis use. Those are the quality stocks we focus on in “Cannabis Corner.” VIVO CANNABIS, $0.025 (Toronto symbol VIVO; TSINetwork Rating: Speculative) (vivocannabis.com; Shares outstanding: 367.1 million; Market cap: $9.3 million; TSI Cannabis Quality Rating [CQR]: ), has received a takeover offer from MediPharm Labs Corp., $0.07, symbol LABS on Toronto. Under the terms of the agreement, holders of shares of Vivo will receive between 0.2110 and 0.4267 common shares of MediPharm for each Vivo share held. That price is subject to adjustment based on working capital held by Vivo. Looking at the combined company: The acquisition of Vivo will let…